Applied DNA Sciences (APDN) Receives a Buy from Maxim Group
In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on Applied DNA Sciences (APDN – Research Report), with a price target of $8.00. The company’s shares closed More »
A Director at Global Blood Therapeutics is Exercising Options
Yesterday it was reported that a Director at Global Blood Therapeutics (GBT – Research Report), Philip Pizzo, exercised options to sell 30,000 GBT shares at $23.65 a share, for a total transaction More »
